IL136137A0 - Hydrophobically-modified protein compositions and methods - Google Patents

Hydrophobically-modified protein compositions and methods

Info

Publication number
IL136137A0
IL136137A0 IL13613798A IL13613798A IL136137A0 IL 136137 A0 IL136137 A0 IL 136137A0 IL 13613798 A IL13613798 A IL 13613798A IL 13613798 A IL13613798 A IL 13613798A IL 136137 A0 IL136137 A0 IL 136137A0
Authority
IL
Israel
Prior art keywords
protein
hydrophobically
methods
hydrophobic moiety
modified protein
Prior art date
Application number
IL13613798A
Other languages
English (en)
Original Assignee
Biogen Inc
Ontogeny Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Inc, Ontogeny Inc filed Critical Biogen Inc
Publication of IL136137A0 publication Critical patent/IL136137A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Graft Or Block Polymers (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL13613798A 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods IL136137A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6742397P 1997-12-03 1997-12-03
US7893598P 1998-03-20 1998-03-20
US8968598P 1998-06-17 1998-06-17
US9980098P 1998-09-10 1998-09-10
PCT/US1998/025676 WO1999028343A2 (fr) 1997-12-03 1998-12-03 Compositions a base de proteines modifiees sur le plan hydrophobe et procedes d'elaboration

Publications (1)

Publication Number Publication Date
IL136137A0 true IL136137A0 (en) 2001-05-20

Family

ID=27490628

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13613798A IL136137A0 (en) 1997-12-03 1998-12-03 Hydrophobically-modified protein compositions and methods
IL136137A IL136137A (en) 1997-12-03 2000-05-14 Isolated hedgehog proteins and methods for their preparation

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL136137A IL136137A (en) 1997-12-03 2000-05-14 Isolated hedgehog proteins and methods for their preparation

Country Status (26)

Country Link
US (1) US6444793B1 (fr)
EP (1) EP1036092B1 (fr)
JP (1) JP4289788B2 (fr)
KR (1) KR20010032753A (fr)
CN (1) CN1294595A (fr)
AT (1) ATE295372T1 (fr)
AU (1) AU757497B2 (fr)
BR (1) BR9815142A (fr)
CA (1) CA2309806A1 (fr)
CZ (1) CZ20002008A3 (fr)
DE (1) DE69830192T2 (fr)
DK (1) DK1036092T3 (fr)
EA (1) EA003739B1 (fr)
EE (1) EE200000308A (fr)
ES (1) ES2243018T3 (fr)
HK (1) HK1030953A1 (fr)
HU (1) HUP0100535A3 (fr)
IL (2) IL136137A0 (fr)
IS (1) IS2163B (fr)
MX (1) MXPA00005494A (fr)
NO (1) NO20002789L (fr)
NZ (1) NZ504752A (fr)
PL (1) PL197833B1 (fr)
PT (1) PT1036092E (fr)
TR (1) TR200001612T2 (fr)
WO (1) WO1999028343A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1034269A1 (fr) * 1997-11-28 2000-09-13 Roche Diagnostics GmbH Mutant actif de proteine du herisson, son procede de preparation et son utilisation a des fins pharmaceutiques
US6897297B1 (en) 1997-12-03 2005-05-24 Curis, Inc. Hydrophobically-modified protein compositions and methods
EA003739B1 (ru) 1997-12-03 2003-08-28 Байоджен, Инк. Гидрофобно-модифицированные белки, способы их получения и их применение
EP0953576B1 (fr) * 1998-04-30 2005-11-02 Curis, Inc. Conjugué de protéine hedgehog active, procédé pour sa production et utilisation
TW570805B (en) 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
CA2348773C (fr) * 1998-11-02 2010-04-13 Biogen, Inc. Antagonistes fonctionnels de l'activite hedgehog
DE69931390T2 (de) * 1998-12-03 2007-06-06 Curis, Inc., Cambridge Verfahren und Zusammensetzungen zur Behandlung von Krankheiten bei denen Excitotoxizität beteiligt ist
EP1025861A1 (fr) * 1999-02-04 2000-08-09 Roche Diagnostics GmbH Compositions pharmaceutiques des Proteines Hedgehog rendues hydrophobes, et leur utilisation
CA2375700A1 (fr) * 1999-06-01 2000-12-07 Biogen, Inc. Conjugues polymeres de proteines hedgehog et leurs utilisations
US7479539B1 (en) 1999-11-05 2009-01-20 Curis, Inc. Hedgehog fusion proteins
AU2005203058C1 (en) * 1999-11-05 2009-07-02 Curis, Inc. Hedgehog fusion proteins and uses
AU2001255767A1 (en) * 2000-04-28 2001-11-12 Curis, Inc. Methods and reagents for tissue engineering of cartilage in vitro
EP1504111A4 (fr) * 2002-04-19 2005-11-23 California Inst Of Techn Bibliotheque de molecules d'acides nucleiques et de peptides dont les peptides contiennent des residus d'acides amines non naturels, et methodes de production associee
EP2359842A1 (fr) 2004-07-14 2011-08-24 University of Utah Research Foundation Compositions et utilisations liees a des netrines
EP1862180A4 (fr) * 2005-03-25 2010-09-15 Takeda Pharmaceutical Agent prophylactique et therapeutique contre le cancer
JP2009515869A (ja) * 2005-11-11 2009-04-16 プロテオジェン バイオ エッセ．エッレ．エッレ． 水溶性活性タンパク質を疎水性活性タンパク質に変換する方法、配向した活性タンパク質の単分子層を調製するための該方法の使用、及び該単分子層を含むデバイス
US8273747B2 (en) 2006-11-02 2012-09-25 Curis, Inc. Small organic molecule regulators of cell proliferation
KR100876657B1 (ko) * 2007-10-15 2009-01-07 한국기계연구원 표면개질된 마이크로비드와 마이크로비드 어레이칩의제조방법과 마이크로비드 어레이칩을 이용한 질병특이항원의 확인방법
EP2247613B1 (fr) * 2008-02-21 2018-05-30 Dermacare Neuroscience Institute Formulations cosmétiques et dermatologiques de peptides mntf
WO2009108868A2 (fr) * 2008-02-27 2009-09-03 Radiomedix Inc. Dérivés hedgehog radiomarqués utilisés en imagerie et en thérapie
UA107571C2 (xx) * 2009-04-03 2015-01-26 Фармацевтична композиція
CN103665095A (zh) * 2012-09-11 2014-03-26 中国人民解放军军事医学科学院卫生学环境医学研究所 一种疏水性多肽修饰抗体的合成方法
CN106928454B (zh) * 2015-12-30 2021-07-20 北京大学 聚氨基酸化合物
CN108147990B (zh) * 2016-12-02 2023-01-24 上海中医药大学 一种膜锚定元件及其应用
AU2018355325A1 (en) 2017-10-25 2020-05-07 Ac Immune S.A. Compositions of phosphorylated tau peptides and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374548A (en) * 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5399347A (en) 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5409611A (en) * 1988-03-24 1995-04-25 Terrapin Technoogies, Inc. Method to identify analyte-binding ligands
US5130297A (en) 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5824315A (en) * 1993-10-25 1998-10-20 Anergen, Inc. Binding affinity of antigenic peptides for MHC molecules
US6281332B1 (en) * 1994-12-02 2001-08-28 The Johns Hopkins University School Of Medicine Hedgehog-derived polypeptides
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
EP0966478A4 (fr) * 1996-10-07 2002-08-21 Univ Johns Hopkins Med Nouveaux polypeptides derives d'une proteine herisson
EA003739B1 (ru) 1997-12-03 2003-08-28 Байоджен, Инк. Гидрофобно-модифицированные белки, способы их получения и их применение

Also Published As

Publication number Publication date
EP1036092A2 (fr) 2000-09-20
NZ504752A (en) 2002-10-25
HK1030953A1 (en) 2001-05-25
TR200001612T2 (tr) 2001-01-22
EA200000605A1 (ru) 2000-12-25
AU1996699A (en) 1999-06-16
HUP0100535A2 (hu) 2001-06-28
DE69830192T2 (de) 2006-01-12
BR9815142A (pt) 2000-10-10
JP4289788B2 (ja) 2009-07-01
KR20010032753A (ko) 2001-04-25
CA2309806A1 (fr) 1999-06-10
MXPA00005494A (es) 2003-05-19
AU757497B2 (en) 2003-02-20
PT1036092E (pt) 2005-09-30
IL136137A (en) 2009-09-22
EA003739B1 (ru) 2003-08-28
EE200000308A (et) 2001-10-15
EP1036092B1 (fr) 2005-05-11
WO1999028343A9 (fr) 1999-10-14
IS5499A (is) 2000-05-15
PL341430A1 (en) 2001-04-09
PL197833B1 (pl) 2008-04-30
WO1999028343A3 (fr) 1999-08-12
CN1294595A (zh) 2001-05-09
NO20002789D0 (no) 2000-05-31
DK1036092T3 (da) 2005-08-15
CZ20002008A3 (cs) 2001-11-14
ATE295372T1 (de) 2005-05-15
JP2001525336A (ja) 2001-12-11
DE69830192D1 (de) 2005-06-16
HUP0100535A3 (en) 2003-09-29
IS2163B (is) 2006-11-15
US6444793B1 (en) 2002-09-03
ES2243018T3 (es) 2005-11-16
NO20002789L (no) 2000-08-02
WO1999028343A2 (fr) 1999-06-10

Similar Documents

Publication Publication Date Title
IL136137A0 (en) Hydrophobically-modified protein compositions and methods
De Caro et al. Porcine pancreatic lipase. Completion of the primary structure
IL115199A (en) Composition comprising a polynucleic acid molecule in a liposome and method using said composition
AR056723A2 (es) Polipeptido purificado metodo para producirlo , metodo para identificarlo y/ o aislarlo composicion farmaceutica que lo comprende, secuencia de acidos nucleicos aislada que codifica dicho polipeptido, vector que contiene a dicha secuencia celula huesped transfectada por dicho vector, sonda nucleotid
WO1996034107A3 (fr) Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations
AU4981101A (en) Subtilisin variants
CA2301046A1 (fr) Proteines marquees 13c, 15n, 2h destinees a des determinations de structure par rmn et procede de preparation associe
BR9811675A (pt) Genes isolados para proteìna da membrana de célula dentrìtica
WO1999006557A3 (fr) Proteines de membrane cellulaire mammalienne et reactifs associes
WO1999028876A3 (fr) Compositions proteiniques modifiees de maniere hydrophobe et leurs procedes de fabrication
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
WO1999022005A3 (fr) D-glucosaminyle 3-o-sulfotransferases de sulfate d'heparane et utilisations associees
CY1105486T1 (el) Τροποποιημενες υδροφοβικα συνθεσεις πρωτεϊνων ακανθοχοιρου και μεθοδοι παρασκευης αυτων
WO2001042287A3 (fr) Nouvelles proteines membranaires humaines et polynucleotides codant pour ces proteines
AU3063699A (en) Isolated mammalian membrane protein genes and related reagents
WO2002012541A3 (fr) Nouvelles proteines moteurs et leurs procedes d'utilisation
WO2001096593A3 (fr) Nouvelles proteines motrices et procedes d'utilisation de ces proteines
AU2001235894A1 (en) Novel mammalian secreted group iii phospholipase a2
WO2002079479A3 (fr) Nouvelle proteines moteur et procede d'utilisation
WO2000034335A3 (fr) Genes mammiferes et reactifs connexes
BR0213772A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
WO2000032746A3 (fr) Acides nucleiques et polypeptides netrinoïdes et ependyminoïdes et leurs utilisations
WO2001098314A3 (fr) Proteines motrices et modalites d'utilisation
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
RU94046405A (ru) Птг-соединения и содержащий их фармацевтический состав, способ получения желаемых полипептидов, нуклеотидная последовательность, бактериальный вектор экспрессии, бактериальные хозяйские клетки и составной белок